Libertas 7 SA
MAD:LIB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Libertas 7 SA
MAD:LIB
|
ES |
|
Oneview Healthcare PLC
ASX:ONE
|
IE |
|
Swiss Steel Holding AG
SIX:STLN
|
CH |
|
C
|
Canopy Holdings AS
OSE:CAN
|
NO |
|
Cannabis Sativa Inc
OTC:CBDS
|
US |
|
Argeo AS
F:8W2
|
NO |
|
N
|
Nestcon Bhd
KLSE:NESTCON
|
MY |
|
Clover Health Investments Corp
NASDAQ:CLOV
|
US |
|
L
|
Lucas Bols Amsterdam BV
F:LUA
|
NL |
|
KTL Global Ltd
SGX:EB7
|
SG |
|
Warteck Invest AG
SIX:WARN
|
CH |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LIB's stock price target?
Not Available
LIB doesn't have any price targets made by Wall Street professionals.
What is Libertas 7 SA's Revenue forecast?
Projected CAGR
30%
For the last 14 years the compound annual growth rate for Libertas 7 SA's revenue is 2%. The projected CAGR for the next 2 years is 30%.
What is Libertas 7 SA's Operating Income forecast?
Projected CAGR
27%
For the last 14 years the compound annual growth rate for Libertas 7 SA's operating income is 26%. The projected CAGR for the next 3 years is 27%.
What is Libertas 7 SA's Net Income forecast?
Projected CAGR
-91%
The compound annual growth rate of Libertas 7 SA's net income for the next 2 years is -91%.